Fei Yan, Junzheng Yang, Meihua Gong, Guangheng Li, Li Yu
{"title":"Effect of hucMSC-derived Exosomes on the Pressure Ulcers in Mice.","authors":"Fei Yan, Junzheng Yang, Meihua Gong, Guangheng Li, Li Yu","doi":"10.2174/0115665240450312260206114749","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Pressure ulcers (PUs) are a result of sustained compression of the local skin, leading to impaired blood circulation and subsequent nutritional deficiencies in the skin and subcutaneous tissues. Exosomes are one type of extracellular vesicle with a size range of 40 to 160 nm. Currently, the effects of Human umbilical cord mesenchymal stem cell-derived exosomes (hucMSC-exos) on the PUs and the underlying mechanisms remain largely unexplored.</p><p><strong>Methods: </strong>In this study, a PUs model was constructed using BALB/c mice, and the effect of hucMSC-exos on the PUs mice was evaluated by using histopathological examination, quantitative real-time polymerase chain reaction (qRT-PCR), and western blotting.</p><p><strong>Results: </strong>The results of HE staining and Masson staining demonstrated that the treatment of hucMSC-exos could alleviate the histopathological changes of mice. Furthermore, the results of qPCR demonstrated that hucMSC-exos decreased the levels of collagen I, collagen III, and α-SMA in PUs mice; and the results of western blotting demonstrated that the expressions of HMGB1 and α-SMA could be decreased by the administration of hucMSC-exos.</p><p><strong>Discussion: </strong>The data in the manuscript suggest that hucMSC-exos are both safe and effective in the treatment of PUs. It is recommended that large-scale animal experiments and long-term administration time of hucMSC-exos should be conducted to further verify the effect of hucMSC-exos in PUs.</p><p><strong>Conclusion: </strong>The findings of this study demonstrated that hucMSC-exos alleviated the symptoms of PU mice by regulating HGMB1 and α-SMA, thus demonstrating the therapeutic potential of hucMSC-exos in PUs.</p>","PeriodicalId":10873,"journal":{"name":"Current molecular medicine","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2026-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current molecular medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115665240450312260206114749","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Pressure ulcers (PUs) are a result of sustained compression of the local skin, leading to impaired blood circulation and subsequent nutritional deficiencies in the skin and subcutaneous tissues. Exosomes are one type of extracellular vesicle with a size range of 40 to 160 nm. Currently, the effects of Human umbilical cord mesenchymal stem cell-derived exosomes (hucMSC-exos) on the PUs and the underlying mechanisms remain largely unexplored.
Methods: In this study, a PUs model was constructed using BALB/c mice, and the effect of hucMSC-exos on the PUs mice was evaluated by using histopathological examination, quantitative real-time polymerase chain reaction (qRT-PCR), and western blotting.
Results: The results of HE staining and Masson staining demonstrated that the treatment of hucMSC-exos could alleviate the histopathological changes of mice. Furthermore, the results of qPCR demonstrated that hucMSC-exos decreased the levels of collagen I, collagen III, and α-SMA in PUs mice; and the results of western blotting demonstrated that the expressions of HMGB1 and α-SMA could be decreased by the administration of hucMSC-exos.
Discussion: The data in the manuscript suggest that hucMSC-exos are both safe and effective in the treatment of PUs. It is recommended that large-scale animal experiments and long-term administration time of hucMSC-exos should be conducted to further verify the effect of hucMSC-exos in PUs.
Conclusion: The findings of this study demonstrated that hucMSC-exos alleviated the symptoms of PU mice by regulating HGMB1 and α-SMA, thus demonstrating the therapeutic potential of hucMSC-exos in PUs.
期刊介绍:
Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews/ mini-reviews, original research articles, short communications/letters and drug clinical trial studies on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal invites guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.